|
Several midcap stocks are delivering strong returns on equity above 50%, reflecting efficient management and solid business models. High RoE indicates financial health and growth potential.
Category:
News and Media
Shares of TCS and Infosys jumped over 3% after Investec and JP Morgan upgraded ratings with higher targets, citing long-term IT resilience. Analysts see recovery in H2 FY26, driven by AI-led transformation, cost efficiency, and robust order books despite near-term demand pressures.
Category:
News and Media
Cohance Lifesciences, Divis Laboratories, and SAI Life Sciences rallied after Jefferies initiated coverage with Buy ratings, citing strong growth prospects in Indias CRDMO sector. The brokerage sees a high-teen revenue CAGR, led by China+1 diversification, pipeline visibility, and demand for diabetes and weight-loss therapies.
Category:
News and Media
All news |
||||||||||||||||||
|